Literature DB >> 15793645

Surgical salvage of recurrent rectal cancer after transanal excision.

Martin R Weiser1, Ron G Landmann, W Douglas Wong, Jinru Shia, José G Guillem, Larissa K Temple, Bruce D Minsky, Alfred M Cohen, Philip B Paty.   

Abstract

PURPOSE: This study examines surgical salvage of locally recurrent rectal cancer following transanal excision of early tumors.
METHODS: Through retrospective review of a colorectal database we identified 50 patients who underwent attempted surgical salvage for local recurrence following initial transanal excision of T1 or T2 rectal cancer. Eight patients had resectable synchronous distant disease. Clinicopathologic variables were associated with extent of surgery required for salvage and outcome.
RESULTS: Salvage procedures included abdominoperineal resection (31), low anterior resection (11), total pelvic exenteration (4), and transanal excision (3). One patient had unresectable disease at exploration, requiring diverting ostomy. Of the 49 patients who underwent successful salvage, 27 (55 percent) required an extended pelvic dissection with en bloc resection of one or more of the following structures: pelvic sidewall and autonomic nerves (18); coccyx or portion of sacrum (6); prostate (5); seminal vesicle (5); bladder (4); portion of the vagina (3); ureter (2); ovary (1); and uterus (1). Complete pathologic resection (R0) was accomplished in 47 of 49 patients. Of the eight patients with distant and local recurrence, two underwent synchronous resection and six had delayed metastasectomy. With a median follow-up of 33 months, 29 patients had recurred or died of disease at the time of this analysis. Five-year disease-specific survival was 53 percent. Factors predictive of survival included evidence of any mucosal recurrence on endoscopy, low presalvage carcinoembryonic antigen, and absence of poor pathologic features (lymphovascular and perineural invasion). Patients who required an extended pelvic resection had a worse survival rate.
CONCLUSION: Pelvic recurrence following transanal excision of early rectal cancer is often locally advanced, requiring an extended pelvic dissection with en bloc resection of adjacent pelvic organs to achieve salvage. The long-term outcome in patients undergoing resection is less than expected, considering the early stage of their initial disease. When contemplating local excision for early rectal cancer, the risk of local recurrence, the extent and morbidity of surgery required for salvage, and the modest cure rate following salvage should be considered.

Entities:  

Mesh:

Year:  2005        PMID: 15793645     DOI: 10.1007/s10350-004-0930-3

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  28 in total

1.  Transanal endoscopic microsurgery for rectal cancer. Long-term oncologic results.

Authors:  Jose M Ramirez; Vicente Aguilella; Javier Valencia; Javier Ortego; Jose A Gracia; Pilar Escudero; Ricardo Esco; Mariano Martinez
Journal:  Int J Colorectal Dis       Date:  2011-01-27       Impact factor: 2.571

Review 2.  Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation.

Authors:  Patricio B Lynn; Paul Strombom; Julio Garcia-Aguilar
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

3.  [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].

Authors:  T Sprenger; H Rothe; T Beissbarth; L-C Conradi; A Kauffels; K Homayounfar; C L Behnes; C Rödel; T Liersch; M Ghadimi
Journal:  Chirurg       Date:  2016-07       Impact factor: 0.955

Review 4.  Management of Rectal Polyps.

Authors:  Michelle L Cowan; Matthew L Silviera
Journal:  Clin Colon Rectal Surg       Date:  2016-12

5.  Analysis of local recurrences after transanal endoscopic microsurgery for low risk rectal carcinoma.

Authors:  Theodor Junginger; Ursula Goenner; Mirjam Hitzler; Tong T Trinh; Achim Heintz; Wilfried Roth; Maria Blettner; Daniel Wollschlaeger
Journal:  Int J Colorectal Dis       Date:  2016-11-25       Impact factor: 2.571

6.  Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the Cancer Care Outcomes Research and Surveillance Consortium.

Authors:  Mary E Charlton; Chi Lin; Dingfeng Jiang; Karyn B Stitzenberg; Thorvardur R Halfdanarson; Jane F Pendergast; Elizabeth A Chrischilles; Robert B Wallace
Journal:  Am J Clin Oncol       Date:  2013-12       Impact factor: 2.339

7.  Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.

Authors:  Keiichi Jingu; Hisanori Ariga; Tomohiro Kaneta; Yoshihiro Takai; Ken Takeda; Lindel Katja; Kakutaro Narazaki; Takahiro Metoki; Keisuke Fujimoto; Rei Umezawa; Yoshihiro Ogawa; Kenji Nemoto; Masashi Koto; Masatoshi Mitsuya; Naruhiro Matsufuji; Shoki Takahashi; Shogo Yamada
Journal:  BMC Cancer       Date:  2010-04-07       Impact factor: 4.430

8.  Are we doing too much?: local excision before radical surgery in early rectal cancer.

Authors:  Sun Min Park; Bong-Hyeon Kye; Min Ki Kim; Heba E Jalloun; Hyeon-Min Cho; In Kyu Lee
Journal:  Int J Colorectal Dis       Date:  2018-02-14       Impact factor: 2.571

9.  Local management of rectal neoplasia.

Authors:  John Touzios; Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2008-11

10.  Recurrences after local excision for early rectal adenocarcinoma.

Authors:  Jung Wook Huh; Yoon Ah Park; Kang Young Lee; Seong Ah Kim; Seung-Kook Sohn
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.